Raymond James Financial »

Xilio Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Xilio Therapeutics

23:59:59.999Dec 30, 202423:59:59.999500:00:00Dec 31, 202400:00:00.000500:00:00.00147.831k47.8315k47.832k47.8325k47.833k50.085k50.0855k50.086k50.0865k50.087k
Value ($)Share countHistorical XLO position of Raymond James Financial Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2024-12-31 $48k 50k 0.96

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Meta Platforms Cl A (META)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Xilio Therapeutics

Gilead Sciences
Bain Capital Life Sciences Investors
Rock Springs Capital Management
RiverVest Venture Management
FMR
Morgan Stanley
Vanguard Group
Geode Capital Management
Balyasny Asset Management
Renaissance Technologies
Trustees of Columbia University in the City of New York
UBS Group
Fil
BlackRock
Bridgeway Capital Management

View all funds holding Xilio Therapeutics